Cocrystal Pharma Inc
Research Cocrystal Pharma Inc (COCP) on Bullrun: market cap USD 15.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCOCP
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 15.58M
- Financial periodQ1 2026
- RevenueUSD 225.00K
- Net income-USD 8.83M
- Free cash flow-USD 7.61M
Valuation Snapshot
latest market cap is USD 15.58M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 8.83M | -USD 8.20M | n/a | -0.78 | USD 7.03M | USD 1.51M | USD 6.33M |
| FY2024 | USD 0 | -USD 17.50M | -USD 16.49M | n/a | -1.72 | USD 9.86M | USD 1.81M | USD 9.52M |
| FY2023 | n/a | -USD 17.98M | -USD 14.78M | n/a | -1.87 | USD 26.35M | USD 1.85M | USD 26.38M |
| FY2022 | n/a | -USD 38.84M | -USD 21.51M | n/a | -4.77 | USD 37.14M | USD 419.00K | USD 39.60M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 15.58M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 13.51M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 20.55M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 17.50M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 15.88M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 63.35M | n/a | n/a | n/a |
About Cocrystal Pharma Inc
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cocrystal Pharma Inc's market cap?
Cocrystal Pharma Inc's market capitalization is USD 15.58M.
What does Cocrystal Pharma Inc do?
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.